Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Prime Medicine, Inc.

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20
   10-K10-K10-K
Revenues  0.00.05.2
            Revenue growth   -100.0% 
Cost of goods sold  0.00.00.0
Gross profit  0.00.05.2
            Gross margin    100.0%
Selling, general and administrative   [+]29.813.93.2
Research and development  86.770.63.0
EBITDA   [+]-114.3-83.9-0.9
            EBITDA margin    -17.1%
Depreciation and amortization  2.20.60.0
EBIT   [+]-116.5-84.5-0.9
            EBIT margin    -17.9%
Other income (expense), net  -7.2-81.91.3
Pre-tax income  -123.7-166.30.3
Income taxes  -0.9-0.51.9
            Tax rate  0.8%0.3%576.2%
Net income  -142.0-184.1-5.1
            Net margin    -97.0%
   
Basic EPS   [+]($4.19)($14.19)($1.91)
Diluted EPS   [+]($4.19)($14.19)($1.91)
   
Shares outstanding (basic)   [+]33.913.02.6
Shares outstanding (diluted)   [+]33.913.02.6
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy